ACE and neoplasm: Studies looking at mice with independently knocked out N- and C-domains of ACE in myeloid cells revealed that this tumor resistance could be attributed to the ACE C-domain, which seemed to induce macrophages to assume an M1 phenotype (Khan, 2019).